DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Cipriani S, Francisci D, Mencarelli A. et al.
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
Circulation 2013;
127: 2114-2124.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.